Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU MDR and IVDR Cybersecurity Measures Not Enough To Prevent Attacks, Warns ENISA

Executive Summary

An expert from the European Union Agency for Cybersecurity (ENISA) has told Medtech Insight that although the new EU Medical Device and IVD Regulations will push developers to make more secure products, regulation is not enough to prevent cyberattacks on devices and digital health systems.

You may also be interested in...



EU’s New Cybersecurity Guidelines: Not Perfect, But Key Signposting For All Involved

How do the EU’s new cybersecurity guidelines expand on the MDR and fit into the myriad other software-related guidance documents the medtech industry has to consider?

Is Enough Being Done About Cybersecurity In The EU? Contradictory Views Raise Regulatory Questions

A recent report from the UK Royal Academy of Engineering suggests that more efforts are needed to ensure cybersecurity protections for medical devices. But a key European industry trade association says that cybersecurity is adequately addressed from a regulatory standpoint in the EU.

EU Lags Behind US In Device Cybersecurity Guidance, But Harmonization On Horizon

The US FDA appears to be ahead of the EU in the effort to issue guidelines specific to medical device cybersecurity. But experts say regulators in the EU are likely to eventually harmonize as part of a global effort to address cybersecurity risks.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145774

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel